APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Exenatide Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Exenatide Injection Market Analysis and Forecast 2026-2032

Report ID 173990230222 December 2025195 pages

Choose your research edition.

Industry ResearchExenatide Injection Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Exenatide Injection Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Exenatide Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Exenatide Injection Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Exenatide Injection Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Exenatide Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Exenatide Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Exenatide Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Exenatide Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Exenatide Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Exenatide Injection include Lilly, Chenfei Pharmaceutical, Baxter Pharmaceutical, AstraZeneca and Amylin, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Exenatide Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Exenatide Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Exenatide Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Exenatide Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Exenatide Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Exenatide Injection sales, projected growth trends, production technology, application and end-user industry.

Exenatide Injection Segment by Company

Lilly

Chenfei Pharmaceutical

Baxter Pharmaceutical

AstraZeneca

Amylin

Exenatide Injection Segment by Type

1.2 ml/Cartridge

2.4 ml/Cartridge

Exenatide Injection Segment by Application

Hospital

Clinic

Pharmacy

Exenatide Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exenatide Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Exenatide Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exenatide Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Exenatide Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Exenatide Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Exenatide Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Exenatide Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 1.2 ml/Cartridge Major Manufacturers Table 3. 2.4 ml/Cartridge Major Manufacturers Table 4. Global Exenatide Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Pharmacy Major Manufacturers Table 8. Exenatide Injection Industry Trends Table 9. Exenatide Injection Industry Drivers Table 10. Exenatide Injection Industry Opportunities and Challenges Table 11. Exenatide Injection Industry Restraints Table 12. Global Exenatide Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Exenatide Injection Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Exenatide Injection Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Exenatide Injection Revenue Market Share by Region (2021-2026) Table 16. Global Exenatide Injection Revenue Market Share by Region (2027-2032) Table 17. Global Exenatide Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Exenatide Injection Sales by Region (2021-2026) & (k units) Table 19. Global Exenatide Injection Sales by Region (2027-2032) & (k units) Table 20. Global Exenatide Injection Sales Market Share by Region (2021-2026) Table 21. Global Exenatide Injection Sales Market Share by Region (2027-2032) Table 22. Global Exenatide Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Exenatide Injection Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Exenatide Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Exenatide Injection Sales Market Share by Manufacturers (2021-2026) Table 26. Global Exenatide Injection Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Exenatide Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Exenatide Injection Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Exenatide Injection Manufacturers, Product Type & Application Table 30. Global Exenatide Injection Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Exenatide Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Exenatide Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Exenatide Injection Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Exenatide Injection Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Exenatide Injection Revenue Market Share by Type (2021-2026) Table 37. Global Exenatide Injection Revenue Market Share by Type (2027-2032) Table 38. Global Exenatide Injection Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Exenatide Injection Sales by Type (2021-2026) & (k units) Table 40. Global Exenatide Injection Sales by Type (2027-2032) & (k units) Table 41. Global Exenatide Injection Sales Market Share by Type (2021-2026) Table 42. Global Exenatide Injection Sales Market Share by Type (2027-2032) Table 43. Global Exenatide Injection Price by Type (2021-2026) & (US$/unit) Table 44. Global Exenatide Injection Price by Type (2027-2032) & (US$/unit) Table 45. Global Exenatide Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Exenatide Injection Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Exenatide Injection Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Exenatide Injection Revenue Market Share by Application (2021-2026) Table 49. Global Exenatide Injection Revenue Market Share by Application (2027-2032) Table 50. Global Exenatide Injection Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Exenatide Injection Sales by Application (2021-2026) & (k units) Table 52. Global Exenatide Injection Sales by Application (2027-2032) & (k units) Table 53. Global Exenatide Injection Sales Market Share by Application (2021-2026) Table 54. Global Exenatide Injection Sales Market Share by Application (2027-2032) Table 55. Global Exenatide Injection Price by Application (2021-2026) & (US$/unit) Table 56. Global Exenatide Injection Price by Application (2027-2032) & (US$/unit) Table 57. Lilly Company Information Table 58. Lilly Business Overview Table 59. Lilly Exenatide Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Lilly Exenatide Injection Product Portfolio Table 61. Lilly Recent Development Table 62. Chenfei Pharmaceutical Company Information Table 63. Chenfei Pharmaceutical Business Overview Table 64. Chenfei Pharmaceutical Exenatide Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Chenfei Pharmaceutical Exenatide Injection Product Portfolio Table 66. Chenfei Pharmaceutical Recent Development Table 67. Baxter Pharmaceutical Company Information Table 68. Baxter Pharmaceutical Business Overview Table 69. Baxter Pharmaceutical Exenatide Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Baxter Pharmaceutical Exenatide Injection Product Portfolio Table 71. Baxter Pharmaceutical Recent Development Table 72. AstraZeneca Company Information Table 73. AstraZeneca Business Overview Table 74. AstraZeneca Exenatide Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. AstraZeneca Exenatide Injection Product Portfolio Table 76. AstraZeneca Recent Development Table 77. Amylin Company Information Table 78. Amylin Business Overview Table 79. Amylin Exenatide Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Amylin Exenatide Injection Product Portfolio Table 81. Amylin Recent Development Table 82. North America Exenatide Injection Revenue by Type (2021-2026) & (US$ Million) Table 83. North America Exenatide Injection Revenue by Type (2027-2032) & (US$ Million) Table 84. North America Exenatide Injection Sales by Type (2021-2026) & (k units) Table 85. North America Exenatide Injection Sales by Type (2027-2032) & (k units) Table 86. North America Exenatide Injection Sales Price by Type (2021-2026) & (US$/unit) Table 87. North America Exenatide Injection Sales Price by Type (2027-2032) & (US$/unit) Table 88. North America Exenatide Injection Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Exenatide Injection Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Exenatide Injection Sales by Application (2021-2026) & (k units) Table 91. North America Exenatide Injection Sales by Application (2027-2032) & (k units) Table 92. North America Exenatide Injection Sales Price by Application (2021-2026) & (US$/unit) Table 93. North America Exenatide Injection Sales Price by Application (2027-2032) & (US$/unit) Table 94. North America Exenatide Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Exenatide Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 96. North America Exenatide Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 97. North America Exenatide Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 98. North America Exenatide Injection Sales by Country (2021-2026) & (k units) Table 99. North America Exenatide Injection Sales by Country (2027-2032) & (k units) Table 100. North America Exenatide Injection Sales Price by Country (2021-2026) & (US$/unit) Table 101. North America Exenatide Injection Sales Price by Country (2027-2032) & (US$/unit) Table 102. United States Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 103. Canada Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 104. Mexico Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 105. Europe Exenatide Injection Revenue by Type (2021-2026) & (US$ Million) Table 106. Europe Exenatide Injection Revenue by Type (2027-2032) & (US$ Million) Table 107. Europe Exenatide Injection Sales by Type (2021-2026) & (k units) Table 108. Europe Exenatide Injection Sales by Type (2027-2032) & (k units) Table 109. Europe Exenatide Injection Sales Price by Type (2021-2026) & (US$/unit) Table 110. Europe Exenatide Injection Sales Price by Type (2027-2032) & (US$/unit) Table 111. Europe Exenatide Injection Revenue by Application (2021-2026) & (US$ Million) Table 112. Europe Exenatide Injection Revenue by Application (2027-2032) & (US$ Million) Table 113. Europe Exenatide Injection Sales by Application (2021-2026) & (k units) Table 114. Europe Exenatide Injection Sales by Application (2027-2032) & (k units) Table 115. Europe Exenatide Injection Sales Price by Application (2021-2026) & (US$/unit) Table 116. Europe Exenatide Injection Sales Price by Application (2027-2032) & (US$/unit) Table 117. Europe Exenatide Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Europe Exenatide Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 119. Europe Exenatide Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 120. Europe Exenatide Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 121. Europe Exenatide Injection Sales by Country (2021-2026) & (k units) Table 122. Europe Exenatide Injection Sales by Country (2027-2032) & (k units) Table 123. Europe Exenatide Injection Sales Price by Country (2021-2026) & (US$/unit) Table 124. Europe Exenatide Injection Sales Price by Country (2027-2032) & (US$/unit) Table 125. Germany Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 126. France Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 127. U.K. Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 128. Italy Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 129. Russia Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 130. Spain Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 131. Netherlands Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 132. Switzerland Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 133. Sweden Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 134. Poland Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 135. China Exenatide Injection Revenue by Type (2021-2026) & (US$ Million) Table 136. China Exenatide Injection Revenue by Type (2027-2032) & (US$ Million) Table 137. China Exenatide Injection Sales by Type (2021-2026) & (k units) Table 138. China Exenatide Injection Sales by Type (2027-2032) & (k units) Table 139. China Exenatide Injection Sales Price by Type (2021-2026) & (US$/unit) Table 140. China Exenatide Injection Sales Price by Type (2027-2032) & (US$/unit) Table 141. China Exenatide Injection Revenue by Application (2021-2026) & (US$ Million) Table 142. China Exenatide Injection Revenue by Application (2027-2032) & (US$ Million) Table 143. China Exenatide Injection Sales by Application (2021-2026) & (k units) Table 144. China Exenatide Injection Sales by Application (2027-2032) & (k units) Table 145. China Exenatide Injection Sales Price by Application (2021-2026) & (US$/unit) Table 146. China Exenatide Injection Sales Price by Application (2027-2032) & (US$/unit) Table 147. Asia Exenatide Injection Revenue by Type (2021-2026) & (US$ Million) Table 148. Asia Exenatide Injection Revenue by Type (2027-2032) & (US$ Million) Table 149. Asia Exenatide Injection Sales by Type (2021-2026) & (k units) Table 150. Asia Exenatide Injection Sales by Type (2027-2032) & (k units) Table 151. Asia Exenatide Injection Sales Price by Type (2021-2026) & (US$/unit) Table 152. Asia Exenatide Injection Sales Price by Type (2027-2032) & (US$/unit) Table 153. Asia Exenatide Injection Revenue by Application (2021-2026) & (US$ Million) Table 154. Asia Exenatide Injection Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia Exenatide Injection Sales by Application (2021-2026) & (k units) Table 156. Asia Exenatide Injection Sales by Application (2027-2032) & (k units) Table 157. Asia Exenatide Injection Sales Price by Application (2021-2026) & (US$/unit) Table 158. Asia Exenatide Injection Sales Price by Application (2027-2032) & (US$/unit) Table 159. Asia Exenatide Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia Exenatide Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. Asia Exenatide Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. Asia Exenatide Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 163. Asia Exenatide Injection Sales by Country (2021-2026) & (k units) Table 164. Asia Exenatide Injection Sales by Country (2027-2032) & (k units) Table 165. Asia Exenatide Injection Sales Price by Country (2021-2026) & (US$/unit) Table 166. Asia Exenatide Injection Sales Price by Country (2027-2032) & (US$/unit) Table 167. Japan Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 168. South Korea Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 169. India Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 170. Australia Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 171. Taiwan Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 172. Southeast Asia Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 173. SAMEA Exenatide Injection Revenue by Type (2021-2026) & (US$ Million) Table 174. SAMEA Exenatide Injection Revenue by Type (2027-2032) & (US$ Million) Table 175. SAMEA Exenatide Injection Sales by Type (2021-2026) & (k units) Table 176. SAMEA Exenatide Injection Sales by Type (2027-2032) & (k units) Table 177. SAMEA Exenatide Injection Sales Price by Type (2021-2026) & (US$/unit) Table 178. SAMEA Exenatide Injection Sales Price by Type (2027-2032) & (US$/unit) Table 179. SAMEA Exenatide Injection Revenue by Application (2021-2026) & (US$ Million) Table 180. SAMEA Exenatide Injection Revenue by Application (2027-2032) & (US$ Million) Table 181. SAMEA Exenatide Injection Sales by Application (2021-2026) & (k units) Table 182. SAMEA Exenatide Injection Sales by Application (2027-2032) & (k units) Table 183. SAMEA Exenatide Injection Sales Price by Application (2021-2026) & (US$/unit) Table 184. SAMEA Exenatide Injection Sales Price by Application (2027-2032) & (US$/unit) Table 185. SAMEA Exenatide Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. SAMEA Exenatide Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. SAMEA Exenatide Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. SAMEA Exenatide Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 189. SAMEA Exenatide Injection Sales by Country (2021-2026) & (k units) Table 190. SAMEA Exenatide Injection Sales by Country (2027-2032) & (k units) Table 191. SAMEA Exenatide Injection Sales Price by Country (2021-2026) & (US$/unit) Table 192. SAMEA Exenatide Injection Sales Price by Country (2027-2032) & (US$/unit) Table 193. Brazil Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 194. Argentina Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 195. Chile Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 196. Colombia Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 197. Peru Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 198. Saudi Arabia Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 199. Israel Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 200. UAE Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 201. Turkey Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 202. Iran Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 203. Egypt Exenatide Injection Revenue (2021-2032) & (US$ Million) Table 204. Key Raw Materials Table 205. Raw Materials Key Suppliers Table 206. Exenatide Injection Distributors List Table 207. Exenatide Injection Customers List Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources Table 211. Primary Sources List of Figures Figure 1. Exenatide Injection Image Figure 2. Global Exenatide Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Exenatide Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 1.2 ml/Cartridge Image Figure 5. 2.4 ml/Cartridge Image Figure 6. Global Exenatide Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Exenatide Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Pharmacy Image Figure 11. Global Exenatide Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Exenatide Injection Revenue (2021-2032) & (US$ Million) Figure 13. Global Exenatide Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Exenatide Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Exenatide Injection Revenue Market Share by Region (2021-2032) Figure 16. Global Exenatide Injection Sales (2021-2032) & (k units) Figure 17. Global Exenatide Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Exenatide Injection Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Exenatide Injection Sales YoY (2021-2032) & (k units) Figure 20. Europe Exenatide Injection Sales YoY (2021-2032) & (k units) Figure 21. China Exenatide Injection Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Exenatide Injection Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Exenatide Injection Sales YoY (2021-2032) & (k units) Figure 24. Global Exenatide Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Exenatide Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Exenatide Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Exenatide Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Exenatide Injection Revenue Market Share by Type (2021-2032) Figure 30. Global Exenatide Injection Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Exenatide Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Exenatide Injection Sales Market Share by Type (2021-2032) Figure 33. Global Exenatide Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Exenatide Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Exenatide Injection Revenue Market Share by Application (2021-2032) Figure 36. Global Exenatide Injection Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Exenatide Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Exenatide Injection Sales Market Share by Application (2021-2032) Figure 39. North America Exenatide Injection Revenue Share by Type (2021-2032) Figure 40. North America Exenatide Injection Sales Share by Type (2021-2032) Figure 41. North America Exenatide Injection Revenue Share by Application (2021-2032) Figure 42. North America Exenatide Injection Sales Share by Application (2021-2032) Figure 43. North America Exenatide Injection Revenue Share by Country (2021-2032) Figure 44. North America Exenatide Injection Sales Share by Country (2021-2032) Figure 45. Europe Exenatide Injection Revenue Share by Type (2021-2032) Figure 46. Europe Exenatide Injection Sales Share by Type (2021-2032) Figure 47. Europe Exenatide Injection Revenue Share by Application (2021-2032) Figure 48. Europe Exenatide Injection Sales Share by Application (2021-2032) Figure 49. Europe Exenatide Injection Revenue Share by Country (2021-2032) Figure 50. Europe Exenatide Injection Sales Share by Country (2021-2032) Figure 51. China Exenatide Injection Revenue Share by Type (2021-2032) Figure 52. China Exenatide Injection Sales Share by Type (2021-2032) Figure 53. China Exenatide Injection Revenue Share by Application (2021-2032) Figure 54. China Exenatide Injection Sales Share by Application (2021-2032) Figure 55. Asia Exenatide Injection Revenue Share by Type (2021-2032) Figure 56. Asia Exenatide Injection Sales Share by Type (2021-2032) Figure 57. Asia Exenatide Injection Revenue Share by Application (2021-2032) Figure 58. Asia Exenatide Injection Sales Share by Application (2021-2032) Figure 59. Asia Exenatide Injection Revenue Share by Country (2021-2032) Figure 60. Asia Exenatide Injection Sales Share by Country (2021-2032) Figure 61. SAMEA Exenatide Injection Revenue Share by Type (2021-2032) Figure 62. SAMEA Exenatide Injection Sales Share by Type (2021-2032) Figure 63. SAMEA Exenatide Injection Revenue Share by Application (2021-2032) Figure 64. SAMEA Exenatide Injection Sales Share by Application (2021-2032) Figure 65. SAMEA Exenatide Injection Revenue Share by Country (2021-2032) Figure 66. SAMEA Exenatide Injection Sales Share by Country (2021-2032) Figure 67. Exenatide Injection Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Exenatide Injection Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 1.2 ml/Cartridge
  • 2.4 ml/Cartridge
Applications
  • Hospital
  • Clinic
  • Pharmacy
Companies covered
  • Lilly
  • Chenfei Pharmaceutical
  • Baxter Pharmaceutical
  • AstraZeneca
  • Amylin

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Exenatide Injection Market by Type
  3. 1.2.1 Global Exenatide Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 1.2 ml/Cartridge
  5. 1.2.3 2.4 ml/Cartridge
  6. 1.3 Exenatide Injection Market by Application
  7. 1.3.1 Global Exenatide Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Pharmacy
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Exenatide Injection Market Dynamics
  1. 2.1 Exenatide Injection Industry Trends
  2. 2.2 Exenatide Injection Industry Drivers
  3. 2.3 Exenatide Injection Industry Opportunities and Challenges
  4. 2.4 Exenatide Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Exenatide Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Exenatide Injection Revenue by Region
  3. 3.2.1 Global Exenatide Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Exenatide Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Exenatide Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Exenatide Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Exenatide Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Exenatide Injection Sales by Region
  9. 3.4.1 Global Exenatide Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Exenatide Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Exenatide Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Exenatide Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Exenatide Injection Revenue by Manufacturers
  2. 4.1.1 Global Exenatide Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Exenatide Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Exenatide Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Exenatide Injection Sales by Manufacturers
  6. 4.2.1 Global Exenatide Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Exenatide Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Exenatide Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Exenatide Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Exenatide Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Exenatide Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Exenatide Injection Manufacturers, Product Type & Application
  13. 4.7 Global Exenatide Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Exenatide Injection Market CR5 and HHI
  16. 4.8.2 2025 Exenatide Injection Tier 1, Tier 2, and Tier 3
5 Exenatide Injection Market by Type
  1. 5.1 Global Exenatide Injection Revenue by Type
  2. 5.1.1 Global Exenatide Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Exenatide Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Exenatide Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Exenatide Injection Sales by Type
  6. 5.2.1 Global Exenatide Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Exenatide Injection Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Exenatide Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Exenatide Injection Price by Type
6 Exenatide Injection Market by Application
  1. 6.1 Global Exenatide Injection Revenue by Application
  2. 6.1.1 Global Exenatide Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Exenatide Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Exenatide Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Exenatide Injection Sales by Application
  6. 6.2.1 Global Exenatide Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Exenatide Injection Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Exenatide Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Exenatide Injection Price by Application
7 Company Profiles
  1. 7.1 Lilly
  2. 7.1.1 Lilly Company Information
  3. 7.1.2 Lilly Business Overview
  4. 7.1.3 Lilly Exenatide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Lilly Exenatide Injection Product Portfolio
  6. 7.1.5 Lilly Recent Developments
  7. 7.2 Chenfei Pharmaceutical
  8. 7.2.1 Chenfei Pharmaceutical Company Information
  9. 7.2.2 Chenfei Pharmaceutical Business Overview
  10. 7.2.3 Chenfei Pharmaceutical Exenatide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Chenfei Pharmaceutical Exenatide Injection Product Portfolio
  12. 7.2.5 Chenfei Pharmaceutical Recent Developments
  13. 7.3 Baxter Pharmaceutical
  14. 7.3.1 Baxter Pharmaceutical Company Information
  15. 7.3.2 Baxter Pharmaceutical Business Overview
  16. 7.3.3 Baxter Pharmaceutical Exenatide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Baxter Pharmaceutical Exenatide Injection Product Portfolio
  18. 7.3.5 Baxter Pharmaceutical Recent Developments
  19. 7.4 AstraZeneca
  20. 7.4.1 AstraZeneca Company Information
  21. 7.4.2 AstraZeneca Business Overview
  22. 7.4.3 AstraZeneca Exenatide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 AstraZeneca Exenatide Injection Product Portfolio
  24. 7.4.5 AstraZeneca Recent Developments
  25. 7.5 Amylin
  26. 7.5.1 Amylin Company Information
  27. 7.5.2 Amylin Business Overview
  28. 7.5.3 Amylin Exenatide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Amylin Exenatide Injection Product Portfolio
  30. 7.5.5 Amylin Recent Developments
8 North America
  1. 8.1 North America Exenatide Injection Market Size by Type
  2. 8.1.1 North America Exenatide Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Exenatide Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Exenatide Injection Price by Type (2021-2032)
  5. 8.2 North America Exenatide Injection Market Size by Application
  6. 8.2.1 North America Exenatide Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Exenatide Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Exenatide Injection Price by Application (2021-2032)
  9. 8.3 North America Exenatide Injection Market Size by Country
  10. 8.3.1 North America Exenatide Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Exenatide Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Exenatide Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Exenatide Injection Market Size by Type
  2. 9.1.1 Europe Exenatide Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Exenatide Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Exenatide Injection Price by Type (2021-2032)
  5. 9.2 Europe Exenatide Injection Market Size by Application
  6. 9.2.1 Europe Exenatide Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Exenatide Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Exenatide Injection Price by Application (2021-2032)
  9. 9.3 Europe Exenatide Injection Market Size by Country
  10. 9.3.1 Europe Exenatide Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Exenatide Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Exenatide Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Exenatide Injection Market Size by Type
  2. 10.1.1 China Exenatide Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Exenatide Injection Sales by Type (2021-2032)
  4. 10.1.3 China Exenatide Injection Price by Type (2021-2032)
  5. 10.2 China Exenatide Injection Market Size by Application
  6. 10.2.1 China Exenatide Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Exenatide Injection Sales by Application (2021-2032)
  8. 10.2.3 China Exenatide Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Exenatide Injection Market Size by Type
  2. 11.1.1 Asia Exenatide Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Exenatide Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Exenatide Injection Price by Type (2021-2032)
  5. 11.2 Asia Exenatide Injection Market Size by Application
  6. 11.2.1 Asia Exenatide Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Exenatide Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Exenatide Injection Price by Application (2021-2032)
  9. 11.3 Asia Exenatide Injection Market Size by Country
  10. 11.3.1 Asia Exenatide Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Exenatide Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Exenatide Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Exenatide Injection Market Size by Type
  2. 12.1.1 SAMEA Exenatide Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Exenatide Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Exenatide Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Exenatide Injection Market Size by Application
  6. 12.2.1 SAMEA Exenatide Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Exenatide Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Exenatide Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Exenatide Injection Market Size by Country
  10. 12.3.1 SAMEA Exenatide Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Exenatide Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Exenatide Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Exenatide Injection Value Chain Analysis
  2. 13.1.1 Exenatide Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Exenatide Injection Production Mode & Process
  6. 13.2 Exenatide Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Exenatide Injection Distributors
  9. 13.2.3 Exenatide Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst